Glottic cancer: clinical factors affecting irradiation control.
An analysis of the results of 252 patients with glottic larynx cancer treated in the RRTI between January 1965 and December 1971 is given. The patients were treated by orthovoltage radiotherapy and classified according to the UICC/AJC staging system of 1972. The 3-year recurrence-free rates for T1, T2 and T3 are 83, 62, and 60%, respectively. The present series suggest a reduction in disease-free survival for T2 patients from 70% with extraglottic extension or partial immobility to 52% with both extraglottic extension and partial immobility.